Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis D

NCT06649266 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis D

Interventions

DRUG: RBD1016
DRUG: Placebo

Sponsor

Ribocure Pharmaceuticals AB